ScreenerHero

SEERSeer, Inc.

NAS · US · Healthcare · Biotechnology · seer.bio
2.030USD-0.98%Mkt Cap: 112.41M $P/E: —

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap112.41M $
Enterprise Value-18.61M $
Revenue (TTM)14.22M $
Gross Profit8.01M $
Net Income (TTM)-73.60M $
Revenue/Share0.2540 USD
Last Price2.030 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees124
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.98
PEG—
EV/EBITDA0.29
EV/Revenue-1.31
P/S7.87
P/B0.49
EPS (TTM)-1.19
EPS (Forward)-1.02
52W Range
1.55056% of range2.410
52W High2.410 USD
52W Low1.550 USD
Profitability
Gross Margin49.67%
Oper. Margin-542.91%
EBITDA Margin0.00%
Profit Margin-456.60%
ROE-28.38%
ROA-24.86%
Growth
Revenue Growth-23.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-44.45M $
CapEx (TTM)1.80M $
FCF Margin-188.49%
FCF Yield-23.84%
Net Debt-130.46M $
Net Debt/EBITDA2.01
Balance Sheet
Debt/Equity0.09
Current Ratio14.74
Quick Ratio13.87
Book Value/Sh4.081 USD
Cash/Share2.760 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.000 USD
Upside (mean)+97.0%
Target Range4.000 USD – 4.000 USD
# Analysts1
Ownership
Shares Out.55.37M
Float40.53M
Insiders14.52%
Institutions50.78%
Short Interest
Short Ratio0.1d
Short % Float0.37%
Short % Out.0.33%
Shares Short181.48K
Short (prev mo.)130.49K
Technical
SMA 501.987 (+2.1%)
SMA 2001.900 (+6.8%)
Beta1.52
S&P 52W Chg18.16%
Avg Vol (30d)714.49K
Avg Vol (10d)271.84K
Technical Indicators
RSI (14)44.9
MACD0.0142
MACD Signal0.0400
MACD Hist.-0.0258
BB Upper2.275 USD
BB Middle2.112 USD
BB Lower1.949 USD
BB Width15.41%
ATR (14)0.0836 USD
Vol Ratio (20d)0.13x